Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
21-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.4
advertisement
11.4 Prostaglandins
(50)
Showing records 1 to 25
Display all abstracts in classification
11.4 Prostaglandins
Search within classification 11.4 Prostaglandins
84838
Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Shen W
Journal of Ophthalmology
2019; 2019: 9798272
84829
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Craven ER
Drugs
2020; 80: 167-179
84927
Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Yan F
AAPS PharmSciTech
2020; 21: 63
85049
The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Sato K
Current Eye Research
2020; 0: 1-10
85019
Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Wisely CE
Advances in Therapy
2020; 37: 1114-1123
84489
New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Mehran NA
Eye
2020; 34: 72-88
84517
Effect of 6-week washout period on intraocular pressure following chronic prostaglandin analogue treatment: a randomized controlled trial
Lim CW
Canadian Journal of Ophthalmology
2019; 0:
85105
Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Wy S
Korean Journal of Ophthalmology
2020; 34: 19-26
84662
Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Caruso C
International Ophthalmology
2019; 0:
84489
New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Sinha S
Eye
2020; 34: 72-88
84927
Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Liu Y
AAPS PharmSciTech
2020; 21: 63
84517
Effect of 6-week washout period on intraocular pressure following chronic prostaglandin analogue treatment: a randomized controlled trial
Diaconita V
Canadian Journal of Ophthalmology
2019; 0:
85105
Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Kim YK
Korean Journal of Ophthalmology
2020; 34: 19-26
85019
Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Sheng H
Advances in Therapy
2020; 37: 1114-1123
84838
Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Huang B
Journal of Ophthalmology
2019; 2019: 9798272
84662
Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Pacente L
International Ophthalmology
2019; 0:
85049
The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Nakagawa Y
Current Eye Research
2020; 0: 1-10
84829
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Walters T
Drugs
2020; 80: 167-179
84838
Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Yang J
Journal of Ophthalmology
2019; 2019: 9798272
85049
The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Omodaka K
Current Eye Research
2020; 0: 1-10
84829
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Christie WC
Drugs
2020; 80: 167-179
84662
Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Troiano P
International Ophthalmology
2019; 0:
84489
New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Razeghinejad R
Eye
2020; 34: 72-88
84927
Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Han S
AAPS PharmSciTech
2020; 21: 63
84517
Effect of 6-week washout period on intraocular pressure following chronic prostaglandin analogue treatment: a randomized controlled trial
Liu E
Canadian Journal of Ophthalmology
2019; 0:
«
1
2
»
Issue
21-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement